Dr Reddy’s Laboratories (RDY) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Dr. Reddy’s Laboratories has received fines from Germany’s Federal Administration Office for failing to register beneficial owners of its subsidiary companies on time. The fines, totaling over €19,000, were imposed on betapharm Arzneimittel GmbH and Reddy Holding GmbH. Despite this, the company asserts there is no material impact on its financials or operations.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
